{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-009729","form_type":"8-K","ticker":"IRD","cik":"0001228627","company_name":"Opus Genetics, Inc.","filed_at":"2025-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.133094+00:00","generated_at":"2026-05-24T09:46:29.123016+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Opus Genetics reports preliminary FY 2024 net loss of $56.8M, cash burn $25.6M","bullets":["Net loss for FY 2024 expected to be approximately $56.8 million.","Net cash used in operating activities for FY 2024 approximately $25.6 million.","Cash and cash equivalents balance as of Dec 31, 2024 approximately $30.3 million.","All figures are preliminary, unaudited and subject to change upon finalization of audited financials."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-009729","json":"https://secwatch.observer/filing/0001140361-25-009729.json","markdown":"https://secwatch.observer/filing/0001140361-25-009729.md","text":"https://secwatch.observer/filing/0001140361-25-009729.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1228627/000114036125009729/0001140361-25-009729-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1228627/000114036125009729/ef20045937_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T09:46:29.123016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}